Improved life sciences business systems and methods are disclosed. One or
more genomes are scanned for single nucleotide polymorphisms. The
polymorphisms are assigned to haplotype blocks, and representative SNPs
from the haplotype blocks are used in association studies for
pharmaceutical and diagnostic developments.